qXR-CTR vs DeepTek CXR Analyzer
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is an automated, precise measurement of the cardiothoracic ratio (CTR) from chest X-rays. This tool is ideal for clinical settings focused on efficiently screening for or monitoring changes in heart size, particularly in the context of assessing potential heart failure risk. It streamlines the cardiac assessment component of chest X-ray interpretation.
View qXR-CTR →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you require a comprehensive AI-powered computer-assisted detection (CADe) solution for a wide range of chest X-ray pathologies. This tool is best suited for improving overall diagnostic workflow efficiency and accuracy by automatically identifying and highlighting suspicious regions across lung, pleural, and cardiac findings, significantly reducing radiologist workload across diverse cases.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Unknown | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers features like automatic detection and highlighting of suspicious regions, intelligent segregation of scans, and generation of secondary capture DICOM with AI output, which directly enhance a radiologist's workflow and ease of interpretation. While qXR-CTR automates a specific measurement, DeepTek's broader set of workflow-centric features suggests a more comprehensive approach to usability for the end-user.
Clinical Value
DeepTek CXR AnalyzerBoth tools are FDA-cleared and contribute to clinical assessment. However, DeepTek CXR Analyzer provides a broader clinical value by detecting 28 findings across lung, pleural, and cardiac pathologies, aiming to significantly improve diagnostic accuracy and workflow efficiency. qXR-CTR focuses specifically on the cardiothoracic ratio for heart size and potential heart failure risk, which is a more specialized application.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly states a 'pay-per-use' pricing model and offers flexibility as a technology offering or an AI-assisted reporting service, providing more transparency and adaptable options for customers. Additionally, DeepTek claims to reduce radiologist workload by 30-50% and boost productivity by 2x-3x, directly articulating its value proposition. qXR-CTR's pricing details are not publicly disclosed.
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools demonstrate strong foundational enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability, along with cloud and on-premise deployment options. DeepTek CXR Analyzer explicitly highlights 'Seamless DICOM-based PACS integration (on-premise or cloud)' as a key feature, which is crucial for smooth integration into existing hospital radiology workflows.
Innovation
TieBoth tools showcase significant innovation in AI for chest X-ray analysis. DeepTek CXR Analyzer offers a comprehensive CADe solution detecting 28 findings across multiple pathologies with intelligent segregation. Qure.ai's qXR (of which qXR-CTR is a part) also provides automated interpretation with multi-finding detection (~29 findings) and pre-read assistance, indicating a similar breadth of innovative application.
Support & Docs
TieBoth companies provide evidence of comprehensive support and documentation. Qure.ai mentions a 'Qure.ai App User's Manual' with sections for installation, features, configuration, troubleshooting, and FAQs, as well as API documentation. DeepTek refers to a 'user manual' in its FDA submission and offers a 'Gateway Download & Installation Guide' and a 'Resources Hub' with a 'Knowledge Base'.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | qXR-CTR | DeepTek CXR Analyzer |
| Company | Qure.ai Technologies | DeepTek Medical Imaging Pvt |
| Primary Function | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies. |
| Key AI Focus/Pathologies | Automated Cardiothoracic Ratio (CTR) measurement for heart size and potential heart failure risk. | AI-Powered Computer-Assisted Detection (CADe) for 28 findings covering lung, pleural, cardiac pathologies, and hardware; automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'. |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and DeepTek CXR Analyzer.